Log in
Enquire now

List of National Cancer Institute patents

List of National Cancer Institute patents
List of Celcuity patents
List of BioNTech patents
List of CytomX Therapeutics patents
List of Orion Corporation patents
List of SBIR/STTR awards granted to Evigia Systems
Patents where
Current Assignee
Name
is
National Cancer InstituteNational Cancer Institute
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10575920 Augmented reality image projection system

Patent 10575920 was granted and assigned to National Cancer Institute on March, 2020 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
10575920
March 3, 2020
‌
US Patent 8688195 Fluorescent indication clip for surgery

Patent 8688195 was granted and assigned to National Cancer Institute on April, 2014 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
8688195
April 1, 2014
‌
US Patent 12104069 Epidermal penetration type ink composition

Patent 12104069 was granted and assigned to National Cancer Institute on October, 2024 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
12104069
October 1, 2024
‌
US Patent 11123314 Pharmaceutical composition for preventing and treating pancreatic cancer, containing gossypol and phenformin as active ingredients

Patent 11123314 was granted and assigned to National Cancer Institute on September, 2021 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
11123314
September 21, 2021
‌
US Patent 8657761 Apparatus for inserting needle

Patent 8657761 was granted and assigned to National Cancer Institute on February, 2014 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
8657761
February 25, 2014
‌
US Patent 8449461 Surgical retractor

Patent 8449461 was granted and assigned to National Cancer Institute on May, 2013 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
8449461
May 28, 2013
‌
US Patent 10435752 Use of ADCY3 for diagnosis and treatment of gastric cancer

Patent 10435752 was granted and assigned to National Cancer Institute on October, 2019 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
10435752
October 8, 2019
‌
US Patent 9131970 Pin assembly for operation capable of introducing drug

Patent 9131970 was granted and assigned to National Cancer Institute on September, 2015 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
9131970
September 15, 2015
‌
US Patent 7312070 β-catenin oligonucleotide microchip and method for detecting β-catenin mutations employing same

Patent 7312070 was granted and assigned to National Cancer Institute on December, 2007 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7312070
December 25, 2007
‌
US Patent 7780624 Apparatus for treating tumors

Patent 7780624 was granted and assigned to National Cancer Institute on August, 2010 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7780624
August 24, 2010
‌
US Patent 10646460 Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compound

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
10646460
May 12, 2020
‌
US Patent 10042983 Apparatus for cancer diagnosis

Patent 10042983 was granted and assigned to National Cancer Institute on August, 2018 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
10042983
August 7, 2018
‌
US Patent 8541237 Method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging

Patent 8541237 was granted and assigned to National Cancer Institute on September, 2013 by the United States Patent and Trademark Office.

National Cancer Institute
National Cancer Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
8541237
September 24, 2013
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us